Neurocrine Biosciences Inc
2019 Q4 - 2025 Q4 (25 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 1/26/2026 | 2,371 | 0.0% | 16,716 | 12/31/2025 |
| 2025 Q3 | 11/3/2025 | 2,067 | 0.0% | 14,721 | 9/30/2025 |
| 2025 Q2 | 7/21/2025 | 1,573 | 0.0% | 12,513 | 6/30/2025 |
| 2025 Q1 | 4/24/2025 | 1,519 | 0.0% | 13,577 | 3/31/2025 |
| 2024 Q4 | 1/27/2025 | 2,251 | 0.0% | 16,358 | 12/31/2024 |
| 2024 Q3 | 10/23/2024 | 1,546 | 0.0% | 13,433 | 9/30/2024 |
| 2024 Q2 | 7/30/2024 | 515 | 0.0% | 3,832 | 6/30/2024 |
| 2024 Q1 | 5/1/2024 | 1,520 | 0.0% | 13,300 | 3/31/2024 |
| 2023 Q4 | 1/24/2024 | 3,560 | 0.0% | 26,988 | 12/31/2023 |
| 2023 Q3 | 10/26/2023 | 3,297 | 0.0% | 29,062 | 9/30/2023 |
| 2023 Q2 | 8/10/2023 | 3,358 | 0.0% | 35,564 | 6/30/2023 |
| 2023 Q1 | 5/4/2023 | 3,943 | 0.0% | 39,293 | 3/31/2023 |
| 2022 Q4 | 2/9/2023 | 3,191 | 0.0% | 26,630 | 12/31/2022 |
| 2022 Q3 | 11/10/2022 | 3,394 | 0.0% | 32,519 | 9/30/2022 |
| 2022 Q2 | 8/15/2022 | 3,620 | 0.0% | 37,132 | 6/30/2022 |
| 2022 Q1 | 5/10/2022 | 3,605 | 0.0% | 38,442 | 3/31/2022 |
| 2021 Q4 | 2/8/2022 | 3,693 | 0.0% | 43,506 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 4,430 | 0.0% | 46,187 | 9/30/2021 |
| 2021 Q2 | 8/11/2021 | 3,945 | 0.0% | 40,545 | 6/30/2021 |
| 2021 Q1 | 5/13/2021 | 4,050 | 0.0% | 41,650 | 3/31/2021 |
| 2020 Q4 | 2/10/2021 | 4,923 | 0.0% | 51,355 | 12/31/2020 |
| 2020 Q3 | 11/12/2020 | 3,829 | 0.0% | 39,629 | 9/30/2020 |
| 2020 Q2 | 8/11/2020 | 4,689 | 0.0% | 38,443 | 6/30/2020 |
| 2020 Q1 | 5/12/2020 | 4,003 | 0.0% | 46,249 | 3/31/2020 |
| 2019 Q4 | 2/12/2020 | 25,726 | 0.2% | 239,330 | 12/31/2019 |